95P A single-arm, multicenter phase II trial evaluating TQB2450 plus anlotinib combined with paclitaxel and cisplatin in first-line treatment of advanced esophageal squamous cell carcinoma (ESCC)
J. Wang, Ningning Li, Yingwu Guo, Yufeng Cheng et autres
cn (code pays fourni par la source)